Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Brendel

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Human Gene Therapy. Clinical Development|April 18, 2018
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous DiseaseChristian Brendel, Michael Rothe, Giorgia Santilli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cellsGiorgia Santilli, Elena Almarza, Christian Brendel, et al.
Plos One|September 3, 2010
Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infectionJanine Kimpel, Stephen E Braun, Gang Qiu, et al.
The Journal of Clinical Investigation|September 7, 2016
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotypeChristian Brendel, Swaroopa Guda, Raffaele Renella, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2014
CD133-targeted gene transfer into long-term repopulating hematopoietic stem cellsChristian Brendel, Benjamin Goebel, Abriss Daniela, et al.
The Journal of Allergy and Clinical Immunology|February 9, 2016
Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functionsMaren Weisser, Uta M Demel, Stefan Stein, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Scalable assessment of genome editing off-targets associated with genetic variantsJiecong Lin, My Anh Nguyen, Linda Y Lin, et al.
Nature|August 30, 2023
Epitope editing enables targeted immunotherapy of acute myeloid leukaemiaGabriele Casirati, Andrea Cosentino, Adele Mucci, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2015
miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F InductionSwaroopa Guda, Christian Brendel, Raffaele Renella, et al.
Molecular Therapy. Methods & Clinical Development|April 18, 2020
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene TherapyChristian Brendel, Olivier Negre, Michael Rothe, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Human Gene Therapy. Clinical Development|April 18, 2018
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous DiseaseChristian Brendel, Michael Rothe, Giorgia Santilli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cellsGiorgia Santilli, Elena Almarza, Christian Brendel, et al.
Plos One|September 3, 2010
Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infectionJanine Kimpel, Stephen E Braun, Gang Qiu, et al.
The Journal of Clinical Investigation|September 7, 2016
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotypeChristian Brendel, Swaroopa Guda, Raffaele Renella, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2014
CD133-targeted gene transfer into long-term repopulating hematopoietic stem cellsChristian Brendel, Benjamin Goebel, Abriss Daniela, et al.
The Journal of Allergy and Clinical Immunology|February 9, 2016
Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functionsMaren Weisser, Uta M Demel, Stefan Stein, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Scalable assessment of genome editing off-targets associated with genetic variantsJiecong Lin, My Anh Nguyen, Linda Y Lin, et al.
Nature|August 30, 2023
Epitope editing enables targeted immunotherapy of acute myeloid leukaemiaGabriele Casirati, Andrea Cosentino, Adele Mucci, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2015
miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F InductionSwaroopa Guda, Christian Brendel, Raffaele Renella, et al.
Molecular Therapy. Methods & Clinical Development|April 18, 2020
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene TherapyChristian Brendel, Olivier Negre, Michael Rothe, et al.
Pageof 6